Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05890664 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Colchicine After Electrocardioversion for Atrial Fibrillation

Study acronym: COLECTRO-AF
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 4 to 8v5
  2. Primary and study completion dates: Dec 2025 to Mar 2027
    • Study sites: 3 to 4
    • Eligibility criteria revised
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2024 to Apr 14, 2024
    • Secondary endpoints revised (5)
    • Site details revised at 3 of 3 sites
    v3
  4. Start date: Oct 2023 to May 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate whether a 3 month treatment course of low-dose Colchicine decreases the recurrence of Atrial fibrillation (AF) after electrocardioversion (ECV) in patients with AF.
Trial Details
NCT Number NCT05890664
Lead Sponsor University Hospital, Basel, Switzerland
Collaborators: Swiss Heart Foundation, Fondation Machaon, Switzerland, Genf, Foundation for Cardiovascular Research Basel
Conditions
(from sponsor)		 Atrial Fibrillation, Cardiac Arrhythmia
Related terms Arrhythmias, Cardiac, Atrial Fibrillation
Enrollment 416 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov